Autopsy report · NCT02565901
Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
Cause of deathFunding or business
“Terminated due to insufficient funding”
Life of this trial
- Registered 5 months before it started.
- Ran for about 4 years 4 months before it stopped.
- 28 participants enrolled.
- Results were posted on the registry 1 year 4 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- University of Washington
- Sponsor type
- University, hospital or other
- Conditions
- Castration-Resistant Prostate Carcinoma; Metastatic Prostate Carcinoma; Stage IV Prostate Cancer AJCC v7; Metastatic Malignant Neoplasm in the Bone
- Interventions
- Carboplatin; Docetaxel; Laboratory Biomarker Analysis; Sirolimus
- Participants
- 28
- Sites
- 1
- Countries
- United States
Trials that died the same way
- IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery
“Terminated due to lack of funding” - Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
“Terminated due to loss of funding” - Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma
“Terminated due to loss in funding” - The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
“Funding was terminated” - Differential Gene Expression in Lung and Peripheral Blood After Inhaled Allergen Challenge
“funding terminated”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.